Associated comorbidities or advanced age prevent many patients with clinical stage I non-small cell lung carcinoma (NSCLC) from undergoing surgery. For patients such as these, the CyberKnife and its use of fiducial tracking may provide the optimal treatment. In this chapter we will provide a brief overview of Georgetown University Hospital's current treatment approach using the CyberKnife. We will also review its mature outcomes for inoperable stage I NSCLC patients that were treated with the CyberKnife and fiducial tracking.
|Title of host publication||The Revolution of Robotic Stereotactic Radiotherapy (Robotic Radiosurgery) in Lung Cancer|
|Publisher||Nova Science Publishers, Inc.|
|Number of pages||9|
|State||Published - 1 Jul 2014|